Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00036608 · ClinicalTrials.gov registry record · Phase 3

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

A Phase 3 study of Chronic Hepatitis B, sponsored by Bristol-Myers Squibb.

Completed
Registry status
Phase 3
Development phase
20
Study locations

NCT00036608 is a Phase 3 study of Chronic Hepatitis B that has completed, run by Bristol-Myers Squibb. The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00036608, a Phase 3 study of Chronic Hepatitis B, has completed, sponsored by Bristol-Myers Squibb.

COMPLETED
Registry status
Phase 3
Development phase
20
Study locations

Study Summary

The purpose of this clinical research study is to assess the safety and effectiveness of switching to entecavir compared to continued lamivudine in patients with chronic hepatitis B.

Conditions Studied

Chronic Hepatitis B

Interventions

  • DRUG Entecavir

Study Locations (20)

California

  • Local Investigator - La Jolla
  • Local Investigator - Los Angeles
  • Local Investigator - Los Angeles
  • Local Investigator - Orange
  • Local Investigator - San Diego
  • Local Investigator - San Francisco

Florida

  • Local Investigator - Miami
  • Local Investigator - Miami Beach

Georgia

  • Local Investigator - Atlanta
  • Local Investigator - Atlanta

Illinois

  • Local Investigator - Chicago
  • Local Investigator - Chicago

Alabama

  • Local Investigator - Birmingham

Arizona

  • Local Investigator - Tucson

Connecticut

  • Local Investigator - Farmington

Hawaii

  • Local Investigator - Honolulu

Trial Details

FieldValue
Start Date 2002-01
Est. Completion 2005-02
Phase Phase 3

Sponsor

Bristol-Myers Squibb

1,025 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00036608

The ClinicalTrials.gov registry entry for NCT00036608 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Hepatitis B appearing as the primary indexed condition, and to 1 intervention - of which Entecavir is the first listed.

NCT00036608 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT00036608 about?

NCT00036608 is a clinical study titled "A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine". The purpose of this clinical research study is to assess the safety and effectiveness of switching to entecavir compared to continued lamivudine in patients with chronic hepatitis B.

What is the current status of trial NCT00036608?

This trial is currently completed. It is a Phase 3 study. The study started on 2002-01. Estimated completion is 2005-02.

What conditions does trial NCT00036608 study?

This clinical trial studies the following conditions: Chronic Hepatitis B.

What interventions are being tested in trial NCT00036608?

The interventions under investigation include: Entecavir (DRUG).

Who is sponsoring clinical trial NCT00036608?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00036608 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Hepatitis B

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Hepatitis B

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.